O	0	8	Homeobox	Homeobox	NN	B-NP
O	9	14	genes	gene	NNS	I-NP
O	15	17	in	in	IN	B-PP
O	18	31	hematopoiesis	hematopoiesis	NN	B-NP
O	32	35	and	and	CC	O
O	36	50	leukemogenesis	leukemogenesis	NN	B-NP
O	50	51	.	.	.	O

O	53	61	Homeobox	Homeobox	NN	B-NP
O	62	67	genes	gene	NNS	I-NP
O	68	72	have	have	VBP	B-VP
O	73	74	a	a	DT	B-NP
O	75	85	strikingly	strikingly	RB	I-NP
O	86	95	conserved	conserve	VBN	I-NP
O	96	98	61	61	CD	I-NP
O	98	99	-	-	HYPH	I-NP
O	99	104	amino	amino	NN	I-NP
O	105	109	acid	acid	NN	I-NP
O	110	118	sequence	sequence	NN	I-NP
O	118	119	,	,	,	O
O	120	128	encoding	encode	VBG	B-VP
O	129	132	DNA	DNA	NN	B-NP
O	132	133	-	-	HYPH	B-PP
O	133	140	binding	bind	VBG	B-NP
O	141	147	domain	domain	NN	I-NP
O	147	148	.	.	.	O

O	149	153	Some	Some	DT	B-NP
O	154	162	homeobox	homeobox	NN	I-NP
O	163	168	genes	gene	NNS	I-NP
O	168	169	,	,	,	O
O	170	177	located	locate	VBN	B-VP
O	178	180	in	in	IN	B-PP
O	181	185	four	four	CD	B-NP
O	186	194	clusters	cluster	NNS	I-NP
O	195	198	are	be	VBP	B-VP
O	199	209	designated	designate	VBN	I-VP
O	210	213	HOX	HOX	NN	B-NP
O	214	215	A	A	NN	I-NP
O	216	223	through	through	IN	B-PP
O	224	225	D	D	NN	B-NP
O	225	226	,	,	,	O
O	227	232	while	while	IN	B-SBAR
O	233	239	others	other	NNS	B-NP
O	240	243	are	be	VBP	B-VP
O	244	249	known	know	VBN	I-VP
O	250	252	as	as	IN	B-PP
O	253	262	divergent	divergent	JJ	B-NP
O	263	271	homeobox	homeobox	NN	I-NP
O	272	277	genes	gene	NNS	I-NP
O	277	278	.	.	.	O

O	279	283	Many	Many	JJ	B-NP
O	284	295	researchers	researcher	NNS	I-NP
O	296	300	have	have	VBP	B-VP
O	301	313	demonstrated	demonstrate	VBN	I-VP
O	314	318	that	that	IN	B-SBAR
B-Cell	319	332	hematopoietic	hematopoietic	JJ	B-NP
I-Cell	333	338	cells	cell	NNS	I-NP
O	339	346	express	express	VBP	B-VP
O	347	351	many	many	JJ	B-NP
O	352	360	homeobox	homeobox	NN	I-NP
O	361	366	genes	gene	NNS	I-NP
O	366	367	.	.	.	O

O	368	375	Induced	Induce	VBN	B-VP
O	376	380	over	over	AFX	B-NP
O	380	381	-	-	HYPH	I-NP
O	382	385	and	and	CC	O
O	386	391	under	under	IN	B-PP
O	391	392	-	-	HYPH	B-NP
O	392	402	expression	expression	NN	I-NP
O	403	405	of	of	IN	B-PP
O	406	411	these	these	DT	B-NP
O	412	417	genes	gene	NNS	I-NP
O	418	421	has	have	VBZ	B-VP
O	422	426	been	be	VBN	I-VP
O	427	431	used	use	VBN	I-VP
O	432	434	to	to	TO	I-VP
O	435	446	demonstrate	demonstrate	VB	I-VP
O	447	452	their	their	PRP$	B-NP
O	453	459	affect	affect	NN	I-NP
O	460	462	on	on	IN	B-PP
O	463	467	some	some	DT	B-NP
O	468	475	aspects	aspect	NNS	I-NP
O	476	478	of	of	IN	B-PP
O	479	492	hematopoiesis	hematopoiesis	NN	B-NP
O	493	496	and	and	CC	I-NP
O	497	511	leukemogenesis	leukemogenesis	NN	I-NP
O	511	512	.	.	.	O

O	513	521	Recently	Recently	RB	B-ADVP
O	521	522	,	,	,	O
O	523	528	knock	knock	VB	B-VP
O	528	529	-	-	HYPH	O
O	529	532	out	out	RP	B-PRT
O	533	537	mice	mouse	NNS	B-NP
O	538	540	of	of	IN	B-PP
O	541	549	homeobox	homeobox	NN	B-NP
O	550	555	genes	gene	NNS	I-NP
O	556	558	by	by	IN	B-PP
O	559	567	targeted	target	VBN	B-NP
O	568	578	disruption	disruption	NN	I-NP
O	579	583	have	have	VBP	B-VP
O	584	588	also	also	RB	I-VP
O	589	593	been	be	VBN	I-VP
O	594	598	used	use	VBN	I-VP
O	599	601	to	to	TO	B-VP
O	602	609	examine	examine	VB	I-VP
O	610	615	their	their	PRP$	B-NP
O	616	629	hematological	hematological	JJ	I-NP
O	630	636	effect	effect	NN	I-NP
O	636	637	.	.	.	O

O	638	643	There	There	EX	B-NP
O	644	647	are	be	VBP	B-VP
O	648	656	examples	example	NNS	B-NP
O	657	659	of	of	IN	B-PP
O	660	663	the	the	DT	B-NP
O	664	672	aberrant	aberrant	JJ	I-NP
O	673	683	expression	expression	NN	I-NP
O	684	686	of	of	IN	B-PP
O	687	688	a	a	DT	B-NP
O	689	697	homeobox	homeobox	NN	I-NP
O	698	702	gene	gene	NN	I-NP
O	703	710	causing	cause	VBG	B-VP
B-Cancer	711	720	leukemias	leukemia	NNS	B-NP
O	721	723	in	in	IN	B-PP
O	724	730	humans	human	NNS	B-NP
O	730	731	.	.	.	O

O	732	734	In	In	IN	B-PP
B-Cancer	735	738	pre	pre	AFX	B-NP
I-Cancer	738	739	-	-	HYPH	I-NP
I-Cancer	739	740	B	B	NN	I-NP
I-Cancer	741	746	acute	acute	JJ	I-NP
I-Cancer	747	760	lymphoblastic	lymphoblastic	JJ	I-NP
I-Cancer	761	769	leukemia	leukemia	NN	I-NP
O	770	771	(	(	(	O
B-Cancer	771	774	ALL	ALL	NN	B-NP
O	774	775	)	)	)	O
O	776	780	with	with	IN	B-PP
O	781	782	t	t	NN	B-NP
O	782	783	(	(	(	O
O	783	784	1	1	CD	B-NP
O	784	785	;	;	:	O
O	785	787	19	19	CD	O
O	787	788	)	)	)	O
O	789	802	translocation	translocation	NN	B-NP
O	802	803	,	,	,	O
O	804	805	a	a	DT	B-NP
O	806	812	fusion	fusion	NN	I-NP
O	813	820	protein	protein	NN	I-NP
O	821	823	is	be	VBZ	B-VP
O	824	831	created	create	VBN	I-VP
O	832	839	between	between	IN	B-PP
O	840	843	E2A	E2A	NN	B-NP
O	844	847	and	and	CC	O
O	848	849	a	a	DT	B-NP
O	850	858	homeobox	homeobox	NN	I-NP
O	859	863	gene	gene	NN	I-NP
O	864	867	PBX	PBX	NN	I-NP
O	867	868	.	.	.	O

O	869	871	In	In	IN	B-PP
B-Cancer	872	873	T	T	NN	B-NP
I-Cancer	873	874	-	-	HYPH	B-NP
I-Cancer	874	878	cell	cell	NN	I-NP
I-Cancer	879	882	ALL	ALL	NN	I-NP
O	883	887	with	with	IN	B-PP
O	888	889	t	t	NN	B-NP
O	889	890	(	(	(	O
O	890	892	10	10	CD	B-NP
O	892	893	;	;	:	O
O	893	895	14	14	CD	B-NP
O	895	896	)	)	)	O
O	897	910	translocation	translocation	NN	B-NP
O	910	911	,	,	,	O
O	912	915	the	the	DT	B-NP
O	916	919	HOX	HOX	NN	I-NP
O	920	922	11	11	CD	I-NP
O	923	927	gene	gene	NN	I-NP
O	928	930	is	be	VBZ	B-VP
O	931	942	deregulated	deregulate	VBN	I-VP
O	942	943	.	.	.	O

O	944	946	In	In	IN	B-PP
B-Cancer	947	952	acute	acute	JJ	B-NP
I-Cancer	953	960	myeloid	myeloid	JJ	I-NP
I-Cancer	961	969	leukemia	leukemia	NN	I-NP
O	970	971	(	(	(	O
B-Cancer	971	974	AML	AML	NN	B-NP
O	974	975	)	)	)	O
O	976	980	with	with	IN	B-PP
O	981	982	t	t	NN	B-NP
O	982	983	(	(	(	O
O	983	984	7	7	CD	B-NP
O	984	985	;	;	:	O
O	985	987	11	11	CD	B-NP
O	987	988	)	)	)	O
O	989	1002	translocation	translocation	NN	B-NP
O	1002	1003	,	,	,	O
O	1004	1007	the	the	DT	B-NP
O	1008	1011	HOX	HOX	NN	I-NP
O	1012	1014	A9	A9	NN	I-NP
O	1015	1019	gene	gene	NN	I-NP
O	1020	1022	is	be	VBZ	B-VP
O	1023	1033	rearranged	rearrange	VBN	I-VP
O	1033	1034	.	.	.	O

O	1035	1037	In	In	IN	B-PP
O	1038	1042	this	this	DT	B-NP
O	1043	1049	review	review	NN	I-NP
O	1050	1057	article	article	NN	I-NP
O	1057	1058	,	,	,	O
O	1059	1063	many	many	JJ	B-NP
O	1064	1073	functions	function	NNS	I-NP
O	1074	1076	of	of	IN	B-PP
O	1077	1085	homeobox	homeobox	NN	B-NP
O	1086	1091	genes	gene	NNS	I-NP
O	1092	1096	both	both	CC	B-PP
O	1097	1099	at	at	IN	B-PP
O	1100	1103	the	the	DT	B-NP
O	1104	1109	early	early	JJ	I-NP
B-Cell	1110	1114	stem	stem	NN	I-NP
I-Cell	1115	1119	cell	cell	NN	I-NP
O	1120	1125	level	level	NN	I-NP
O	1126	1128	as	as	RB	B-CONJP
O	1129	1133	well	well	RB	I-CONJP
O	1134	1136	as	as	IN	I-CONJP
O	1137	1139	at	at	IN	B-PP
O	1140	1143	the	the	DT	B-NP
O	1144	1149	later	later	JJ	I-NP
O	1150	1156	stages	stage	NNS	I-NP
O	1157	1159	of	of	IN	B-PP
B-Cell	1160	1173	hematopoietic	hematopoietic	JJ	B-NP
O	1174	1189	differentiation	differentiation	NN	I-NP
O	1189	1190	,	,	,	O
O	1191	1194	and	and	CC	O
O	1195	1198	the	the	DT	B-NP
O	1199	1211	leukemogenic	leukemogenic	JJ	I-NP
O	1212	1218	effect	effect	NN	I-NP
O	1219	1221	of	of	IN	B-PP
O	1222	1229	altered	alter	VBN	B-NP
O	1230	1238	homeobox	homeobox	NN	I-NP
O	1239	1244	genes	gene	NNS	I-NP
O	1245	1248	are	be	VBP	B-VP
O	1249	1258	discussed	discuss	VBN	I-VP
O	1258	1259	.	.	.	O

